Valuation Imexpharm Corporation

Stocks

End-of-day quote Ho Chi Minh S.E. 19/08/2026			5-day change	1st Jan Change
37,300.00 ^VND	+0.54%		+0.27%	-28.95%

07-20	Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-02	Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,744,534	-
Change	-	-22.62%	-1.28%	82.69%	11.7%	-28.95%	-
Enterprise Value (EV)	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,744,534	5,744,534
Change	-	-22.62%	-1.28%	82.69%	11.7%	-28.95%	0%
P/E	29.9x	17.2x	15.6x	24.3x	26.6x	16.2x	14.9x
PBR	2.89x	2.11x	1.9x	3.32x	-	2.29x	2.1x
PEG	-	0.5x	1.68x	1.4x	11.68x	1x	1.76x
Capitalization / Revenue	4.1x	2.44x	1.99x	3.28x	3.31x	2.16x	1.99x
EV / Revenue	0x	0x	0x	0x	0x	2.16x	1.99x
EV / EBITDA	-	-	-	-	-	-	-
EV / EBIT	0x	0x	0x	0x	0x	11.7x	10.8x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Dividend per Share ²	649.4	-	-	500	-	1,000	1,000
Rate of return	1.93%	-	-	1.06%	-	2.68%	2.68%
EPS ²	1,126	1,513	1,653	1,932	1,976	2,304	2,499
Distribution rate	57.7%	-	-	25.9%	-	43.4%	40%
Net sales ¹	1,266,597	1,643,707	1,994,037	2,205,120	2,441,085	2,659,000	2,881,000
EBITDA	299,271	-	457,049	521,703	-	-	-
EBIT ¹	234,475	300,992	374,407	403,285	445,003	490,000	532,000
Net income ¹	189,095	233,964	299,556	320,862	349,138	394,000	428,000
Net Debt	-	-	-	-	-	-	-
Reference price ²	33,679.65	26,060.61	25,727.27	47,000.00	52,500.00	37,300.00	37,300.00
Nbr of stocks (in thousands)	154,011	154,011	154,007	154,009	154,009	154,009	-
Announcement Date	20/01/22	17/01/23	19/01/24	20/01/25	20/01/26	-	-

¹VND in Million²VND

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IMEXPHARM CORPORATION	16.1x	-	-	-	218M
ELI LILLY AND COMPANY	35.07x	12.64x	25.79x	0.56%	1,093B
JOHNSON & JOHNSON	30.16x	-	-	1.98%	653B
ABBVIE INC.	33.05x	7.66x	15.93x	2.65%	458B
ROCHE HOLDING AG	20.11x	4.77x	11.83x	2.77%	355B
NOVARTIS AG	21.93x	5.66x	14.07x	2.83%	294B
ASTRAZENECA PLC	20.48x	4.23x	12x	2.08%	248B
AMGEN INC.	26.9x	6.98x	12.39x	2.37%	230B
NOVO NORDISK A/S	13.48x	4.8x	10.06x	3.81%	203B
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	178B
Average	17.34x	6.63x	15.85x	2.37%	371.07B
Weighted average by Cap.	25.04x	8.32x	18.34x	1.93%